Fortress Biotech, Inc. Debt Instrument, Fair Value Disclosure
Fortress Biotech, Inc. (FBIO) had Debt Instrument, Fair Value Disclosure of $14.80 million as of 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2013-05-09
- 2013-03-31: Debt Instrument, Fair Value Disclosure $14.80M.
- 2012-12-31: Debt Instrument, Fair Value Disclosure $14.80M.
- 2012-09-30: Debt Instrument, Fair Value Disclosure $14.80M.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2013-03-31 | $14.80M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $14.80M 10-K · filed 2013-03-18 |
| 2012-09-30 | $14.80M 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |